ACHV SCHEDULE 13G/A: SEC filing

Filed with the SEC on · accession 0001738048-26-000088

ACHV filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. Venrock Healthcare Capital Partners entities and associated individuals filed an amended Schedule 13G reporting beneficial ownership of 5,502,064 shares, or 5.2%, of Achieve Life Sciences common stock as of September 30, 2026.

Summary of the filing

Venrock Healthcare Capital Partners entities and associated individuals filed an amended Schedule 13G reporting beneficial ownership of 5,502,064 shares, or 5.2%, of Achieve Life Sciences common stock as of September 30, 2026. The filing is a passive investment disclosure with no stated intent to influence control of the company.

Key details

Aggregate shares beneficially owned$5.5M
Percent of class beneficially ownedPCT 5
Shares held by VHCP III$3.7M
Shares held by VHCP Co-Investment III$369K
Shares held by VHCP EG$1.4M
Shares outstanding as of August 11, 2026$102.9M
Shares issued upon warrant exercise subsequent to August 11, 2026$2.8M
Reporting person / beneficial ownerVenrock Healthcare Capital Partners III, L.P.
Reporting person / beneficial ownerVHCP Co-Investment Holdings III, LLC
Reporting person / beneficial ownerVenrock Healthcare Capital Partners EG, L.P.
General partner / manager of reporting entitiesVHCP Management III, LLC
General partner of reporting entityVHCP Management EG, LLC
IssuerAchieve Life Sciences, Inc.
Voting member of vhcp management iii and vhcp management egNimish Shah
Voting member of vhcp management iii and vhcp management egBong Y. Koh
Authorized signatory / attorney-in-factSherman G. Souther

✦ Ask GOAX AI about this filing — what it means for ACHV, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for ACHV?

Click here

Frequently asked questions

What did ACHV file with the SEC on Nov 16, 2026?

ACHV filed a SCHEDULE 13G/A (SEC filing). Venrock Healthcare Capital Partners entities and associated individuals filed an amended Schedule 13G reporting beneficial ownership of 5,502,064 shares, or 5.2%, of Achieve Life Sciences common stock as of September 30, 2026. The filing is a passive investment disclosure with no stated intent to influence control of the company.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

Other ACHV SEC filings

Get alerts when ACHV files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days